Bioregenx BRGX Cash Flow Statement (2022-2026)

OTC BRGX
$0.01 +0.00 (+0.00%)
At close: Sep 18, 2026 · 4:00 PM EDT
Reported Financials

Bioregenx Quarterly Cash Flow Statement

Periods 17 quarters
Latest Mar 2026

Bioregenx reported cash from operations of $0.03M and free cash flow of $0.03M for the quarter ended Mar 2026, down 29.4% year over year. This cash flow statement covers 17 quarters of results from Mar 2022 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income -0.04M-0.03M-0.00M-0.03M-0.23M-0.00M-0.00M-0.72M-0.70M-1.11M-0.39M-18.40M-0.27M-0.18M-0.08M-1.02M-0.13M
Share-based CompensationStock Comp. 0.08M2.16M1.65M22.72M22.72M1.36M47.29M47.31M47.31M0.13M43.11M
Gains from Investment SecuritiesGains Investment 0.02M
Cash from OperationsCash from Ops. -0.02M-0.03M-0.01M-0.00M-0.34M-0.65M-0.28M-0.25M-0.10M-0.18M-0.03M-0.01M0.04M0.00M-0.07M0.07M0.03M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles 0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.01M
Amortization of Deferred ChargesAmort. Deferred Charges 0.01M0.01M0.01M0.02M0.00M-0.00M0.00M
Depreciation & Amortization (CF)Dep. & Amort. 0.00M0.00M0.00M0.00M0.50M0.57M0.57M0.57M0.01M0.04M0.01M0.01M0.01M
Change in Working Capital
Change in ReceivablesChange Receivables 0.02M-0.03M0.00M0.02M-0.09M-232.000.01M-0.00M-0.00M0.01M0.04M-0.02M-0.02M
Change in InventoryChange Inventory 0.14M-0.06M-0.08M0.04M-0.00M-0.07M0.01M-0.05M0.03M-0.01M-0.02M-0.00M-0.01M
Change in Account PayablesChange Payables 0.01M0.00M-0.00M0.00M-0.12M-0.27M0.03M0.09M0.13M0.06M0.06M-0.07M0.07M0.07M0.03M0.02M-0.10M
Change in Accured ExpensesChange Accured Exp. 0.03M0.09M0.02M-0.14M-0.04M0.04M0.03M0.04M0.06M-0.11M-0.02M0.05M0.03M
Investing Activities
Capital ExpendituresCapex 0.19M0.01M0.00M
Acquisitions 0.15M0.00M
Cash from Investing ActivitiesCash from Investing -0.20M-0.19M0.00M-0.05M-0.01M-0.00M
Financing Activities
Cash from Financing ActivitiesCash from Financing 0.03M0.01M0.00M0.16M0.41M0.12M0.51M0.28M0.12M0.05M-0.01M-0.01M0.02M0.07M-0.04M-0.05M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued 4.20M
Net Equity Issued and RepurchasedNet Equity Issued 0.34M0.41M0.06M0.53M
Additional items
Exchange Rate EffectFX Effect 0.00M0.01M-942.000.00M519.00-0.00M0.00M-0.00M-0.01M0.01M
Change in Cash -0.02M-0.00M-582.00-865.00-0.17M-0.22M-0.17M0.07M-0.01M-0.06M0.01M-0.01M0.03M-0.04M491.000.02M-0.02M
Free Cash FlowFCF -0.02M-0.03M-0.01M-0.00M-0.34M-0.65M-0.28M-0.25M-0.29M-0.18M-0.03M-0.01M0.04M0.00M-0.08M0.07M0.03M
Net Cash FlowNCF -0.02M-0.00M-582.00-865.00-0.17M-0.24M-0.17M0.07M-0.01M-0.06M0.02M-0.02M0.03M-0.03M-0.01M0.02M-0.02M

Bioregenx Cash Flow Statement API

Pull Bioregenx's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BRGX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY